PP台50A-U 09159.HK 深 沪
已收盘 12-19 16:10:00
13.020
+0.140
+1.09%
华盛通- 最 高13.010
- 今 开13.010
- 成交量 1.14万股
- 最 低 13.010
- 昨 收 12.880
- 总市值 0
- 52周最高 13.610
- 市盈率 静 --
- 换手率 Infinity.00%
- 52周最低 7.780
- 委 比 0.00%
- 总股本 --
- 历史最高 13.400
- 量 比 1.91
- 振 幅 0.00%
- 历史最低 7.780
- 每 手 50
- 风险率 1.30%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多NorthStrive Biosciences Announces Completion of Phase I Strategic Review for EL-22 Targeting Muscle Loss Associated with GLP-1 Weight Loss Drugs and Age-Related Sarcopenia
Northstrive Biosciences Inc. announces completion of Phase I research for its first-in-class oral myostatin-engineered probiotic, EL-22, targeting muscle-wasting conditions, including GLP-1-associated atrophy. Key findings include strong preclinical rationale and unique oral vaccine approach. The company plans Phase 2 trial for GLP-1 users and regulatory engagement for IND filing.
05-22 12:16
